Evaluating the effect of body mass index and 25-hydroxy-vitamin D level on basal cell carcinoma using Mendelian randomization.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
02 10 2023
02 10 2023
Historique:
received:
11
03
2023
accepted:
30
09
2023
medline:
4
10
2023
pubmed:
3
10
2023
entrez:
2
10
2023
Statut:
epublish
Résumé
Basal cell carcinoma (BCC) is the most common cancer with a rising incidence among white-skinned individuals. A number of epidemiological studies have suggested that obesity and serum 25-hydroxy-vitamin D (25(OH)D) levels may affect the arising of BCC. To address this, we selected 443 and 96 single nucleotide polymorphisms (SNPs) associated with body mass index (BMI) and serum level of 25(OH)D from large-scale genome-wide association studies (GWAS), respectively. The univariable and multivariable two-sample Mendelian randomization (MR) analyses were conducted with a series of sensitivity analyses to ensure the results were reliable and reproducible. The results of univariable two-sample MR analysis showed that higher BMI was related to lower risk for BCC (Odds ratio(OR) = 0.90; 95% confidence interval (CI),[0.81,0.99]; p = 0.02). In addition, this causal effect of BMI on BCC still remained (OR = 0.88; 95%CI,[- 0.22, - 0.03], p-value = 0.008) after adjusting for 25(OH)D level in the multivariable MR analysis. However, the results suggested that 25(OH)D level was not associated with BCC(OR = 1.02; 95%CI, [0.94,1.09], p-value = 0.67). In conclusion, similar to the conclusions of retrospective observational studies, the MR results indicate that high BMI is an independent protective factor for BCC. Meanwhile, vitamin D levels may not be causally associated with the risk of basal cell carcinoma and increasing vitamin D supplementation is unlikely to reduce the risk.
Identifiants
pubmed: 37783777
doi: 10.1038/s41598-023-43926-w
pii: 10.1038/s41598-023-43926-w
pmc: PMC10545741
doi:
Substances chimiques
25-hydroxyvitamin D
A288AR3C9H
Vitamin D
1406-16-2
Calcifediol
P6YZ13C99Q
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16552Informations de copyright
© 2023. Springer Nature Limited.
Références
Gallagher, R. P. & Lee, T. K. Adverse effects of ultraviolet radiation: a brief review. Prog Biophys Mol Biol 92, 119–131 (2006).
pubmed: 16580054
doi: 10.1016/j.pbiomolbio.2006.02.011
Dessinioti, C., Antoniou, C., Katsambas, A. & Stratigos, A. J. Basal cell carcinoma: what’s new under the sun. Photochem Photobiol 86, 481–491 (2010).
pubmed: 20550646
doi: 10.1111/j.1751-1097.2010.00735.x
Grant, W. B., Moan, J. & Reichrath, J. Comment on the effects on human health from stratospheric ozone depletion and its interactions with climate change. Photochem Photobiol Sci 6, 912–915 (2007).
pubmed: 17668123
doi: 10.1039/b705482c
Mahamat-Saleh, Y. et al. Mediterranean dietary pattern and skin cancer risk: a prospective cohort study in French women. Am J Clin Nutr 110, 993–1002 (2019).
pubmed: 31380561
doi: 10.1093/ajcn/nqz173
Pothiawala, S., Qureshi, A. A., Li, Y. & Han, J. Obesity and the incidence of skin cancer in US Caucasians. Cancer Causes Control 23, 717–726 (2012).
pubmed: 22450736
pmcid: 3704194
doi: 10.1007/s10552-012-9941-x
Zhang, Y. et al. Body mass index, height and early-onset basal cell carcinoma in a case-control study. Cancer Epidemiol 46, 66–72 (2017).
pubmed: 28039770
doi: 10.1016/j.canep.2016.12.007
Gerstenblith, M. R. et al. Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study. Int J Cancer 131, E149-155 (2012).
pubmed: 21989791
doi: 10.1002/ijc.26480
Gordon-Thomson, C. et al. Protection from ultraviolet damage and photocarcinogenesis by vitamin D compounds. Adv Exp Med Biol 810, 303–328 (2014).
pubmed: 25207373
Ferhatosmanoglu, A., Selcuk, L. B., Arica, D. A., Ersoz, S. & Yayli, S. Frequency of skin cancer and evaluation of risk factors: a hospital-based study from Turkey. J Cosmet Dermatol 21, 6920–6927 (2022).
pubmed: 36062390
doi: 10.1111/jocd.15355
Afzal, S., Nordestgaard, B. G. & Bojesen, S. E. Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study. J Invest Dermatol 133, 629–636 (2013).
pubmed: 23190899
doi: 10.1038/jid.2012.395
Liang, G., Nan, H., Qureshi, A. A. & Han, J. Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in women. PLoS One 7, e35211 (2012).
pubmed: 22493740
pmcid: 3320875
doi: 10.1371/journal.pone.0035211
Hunter, D. J. et al. Diet and risk of basal cell carcinoma of the skin in a prospective cohort of women. Ann Epidemiol 2, 231–239 (1992).
pubmed: 1342273
doi: 10.1016/1047-2797(92)90055-U
Rock, C. L. et al. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity (Silver Spring) 20, 2296–2301 (2012).
pubmed: 22402737
doi: 10.1038/oby.2012.57
Pereira-Santos, M., Costa, P. R., Assis, A. M., Santos, C. A. & Santos, D. B. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 16, 341–349 (2015).
pubmed: 25688659
doi: 10.1111/obr.12239
Smith, G. D. & Ebrahim, S. “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 32, 1–22 (2003).
pubmed: 12689998
doi: 10.1093/ije/dyg070
Sanderson, E. Multivariable Mendelian Randomization and Mediation. Cold Spring Harb Perspect Med 11(2021).
Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry. Hum Mol Genet 27, 3641–3649 (2018).
pubmed: 30124842
pmcid: 6488973
doi: 10.1093/hmg/ddy271
Revez, J. A. et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun 11, 1647 (2020).
pubmed: 32242144
pmcid: 7118120
doi: 10.1038/s41467-020-15421-7
Adolphe, C. et al. Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility. Genome Med 13, 19 (2021).
pubmed: 33549134
pmcid: 7866769
doi: 10.1186/s13073-021-00827-9
Carter, B. D. et al. Smoking and mortality–beyond established causes. N Engl J Med 372, 631–640 (2015).
pubmed: 25671255
doi: 10.1056/NEJMsa1407211
Larsson, S. C. et al. Smoking, alcohol consumption, and cancer: a mendelian randomisation study in UK Biobank and international genetic consortia participants. PLoS Med 17, e1003178 (2020).
pubmed: 32701947
pmcid: 7377370
doi: 10.1371/journal.pmed.1003178
Emdin, C. A., Khera, A. V. & Kathiresan, S. Mendelian Randomization. JAMA 318, 1925–1926 (2017).
pubmed: 29164242
doi: 10.1001/jama.2017.17219
Burgess, S., Thompson, S. G. & Collaboration, C. C. G. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40, 755–764 (2011).
pubmed: 21414999
doi: 10.1093/ije/dyr036
Staley, J. R. et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics 32, 3207–3209 (2016).
pubmed: 27318201
pmcid: 5048068
doi: 10.1093/bioinformatics/btw373
Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37, 658–665 (2013).
pubmed: 24114802
pmcid: 4377079
doi: 10.1002/gepi.21758
Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44, 512–525 (2015).
pubmed: 26050253
pmcid: 4469799
doi: 10.1093/ije/dyv080
Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40, 304–314 (2016).
pubmed: 27061298
pmcid: 4849733
doi: 10.1002/gepi.21965
Lu, L. et al. Body mass index and the risk of basal cell carcinoma: evidence from Mendelian randomization analysis. PeerJ 11, e14781 (2023).
pubmed: 36710862
pmcid: 9881466
doi: 10.7717/peerj.14781
Gilbody, J. S., Aitken, J. & Green, A. What causes basal cell carcinoma to be the commonest cancer?. Aust J Public Health 18, 218–221 (1994).
pubmed: 7948343
doi: 10.1111/j.1753-6405.1994.tb00231.x
Trost, S. G., Owen, N., Bauman, A. E., Sallis, J. F. & Brown, W. Correlates of adults’ participation in physical activity: review and update. Med Sci Sports Exerc 34, 1996–2001 (2002).
pubmed: 12471307
doi: 10.1097/00005768-200212000-00020
Praestegaard, C. et al. Obesity and risks for malignant melanoma and non-melanoma skin cancer: results from a large Danish prospective cohort study. J Invest Dermatol 135, 901–904 (2015).
pubmed: 25290686
doi: 10.1038/jid.2014.438
Tang, J. Y. et al. Lower skin cancer risk in women with higher body mass index: the women’s health initiative observational study. Cancer Epidemiol Biomarkers Prev 22, 2412–2415 (2013).
pubmed: 24042260
doi: 10.1158/1055-9965.EPI-13-0647
Schneider, G., Kirschner, M. A., Berkowitz, R. & Ertel, N. H. Increased estrogen production in obese men. J Clin Endocrinol Metab 48, 633–638 (1979).
pubmed: 429508
doi: 10.1210/jcem-48-4-633
Mancuso, M. et al. Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer. Carcinogenesis 30, 340–347 (2009).
pubmed: 18952596
doi: 10.1093/carcin/bgn243
Tang, J. Y. et al. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women’s health initiative randomized trials. J Natl Cancer Inst 103, 1469–1475 (2011).
pubmed: 21878677
pmcid: 3186783
doi: 10.1093/jnci/djr333
Tang, J. Y. et al. Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men. Cancer Causes Control 21, 387–391 (2010).
pubmed: 19921445
doi: 10.1007/s10552-009-9470-4
Tang, J. Y., So, P. L. & Epstein, E. H. Jr. Novel Hedgehog pathway targets against basal cell carcinoma. Toxicol Appl Pharmacol 224, 257–264 (2007).
pubmed: 17276471
doi: 10.1016/j.taap.2006.12.011
Welsh, J. Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys 523, 107–114 (2012).
pubmed: 22085499
doi: 10.1016/j.abb.2011.10.019
Asgari, M. M. et al. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol 130, 1438–1443 (2010).
pubmed: 20043012
doi: 10.1038/jid.2009.402
Park, S. M. et al. Vitamin D Intake and risk of skin cancer in US women and men. PLoS One 11, e0160308 (2016).
pubmed: 27557122
pmcid: 4996491
doi: 10.1371/journal.pone.0160308
Mahamat-Saleh, Y., Aune, D. & Schlesinger, S. 25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Sci Rep 10, 13151 (2020).
pubmed: 32753685
pmcid: 7403339
doi: 10.1038/s41598-020-70078-y
Ong, J. S. et al. A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization. Nat Commun 12, 246 (2021).
pubmed: 33431812
pmcid: 7801600
doi: 10.1038/s41467-020-20368-w
Walsh, J. S., Bowles, S. & Evans, A. L. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes 24, 389–394 (2017).
pubmed: 28915134
doi: 10.1097/MED.0000000000000371
Bell, N. H., Shaw, S. & Turner, R. T. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest 74, 1540–1544 (1984).
pubmed: 6332830
pmcid: 425325
doi: 10.1172/JCI111568
Gangloff, A., Bergeron, J., Lemieux, I. & Despres, J. P. Changes in circulating vitamin D levels with loss of adipose tissue. Curr Opin Clin Nutr Metab Care 19, 464–470 (2016).
pubmed: 27537278
doi: 10.1097/MCO.0000000000000315
Norval, M. et al. The effects on human health from stratospheric ozone depletion and its interactions with climate change Photochem. Photobiol. Sci. 6, 232 (2007).
doi: 10.1039/b700018a